Skip to main content
. 2019 Oct 1;26(5):e610–e617. doi: 10.3747/co.26.4957

FIGURE 1.

FIGURE 1

Toxicity pattern. Number of toxicities reported over the course of 32 months’ follow-up after treatment with ibrutinib in 64 patients with relapsed or refractory chronic lymphocytic leukemia in Manitoba. Median time to first toxicity was 14 days (95% confidence interval: 11 days to 19 days).